Evidence map›Paper›PMID 40487487›Full record

ReviewIndian journal of dermatology

Potassium Iodide in Dermatology- Recent Advances in Mechanism of Action, Preparation, Uses and Adverse Effects.

Nishant Goel, Bhavana R Doshi

Abstract readReview
In one paragraph

Review in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nishant GoelFrom the Department of Dermatology, Venereology and Leprosy, J. N. Medical College, Belagavi, Karnataka, India.
Bhavana R DoshiFrom the Department of Dermatology, Venereology and Leprosy, J. N. Medical College, Belagavi, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potassium iodide (KI) is a simple yet versatile drug. It has been successfully used for the treatment of various diseases in dermatology, but there are very limited studies on the exact mechanism of action, preparation, and dosage of potassium iodide, causing concerns regarding its toxicity. This article reviews the multimodal mechanism of action of KI and standardises the method of preparation of a saturated solution of potassium iodide (SSKI) on an OPD basis. It also lists the existing and newer indications, optimal dosages, adverse effects, and contraindications of potassium iodide, thereby enabling the proper utilisation of this age-old remedy as a cost-effective yet safe treatment option for various inflammatory dermatoses, including panniculitis (erythema nodosum, erythema induratum, subacute nodular migratory panniculitis), Wegener's granulomatosis, granuloma annulare, Behcet's syndrome, pyoderma gangrenosum, Sweet's syndrome, and erythema multiforme. Potassium iodide is also used for fungal infections, including cutaneous and lymphocutaneous sporotrichosis, cutaneous cryptococcosis, entomophthoramycosis, human pythiosis, chromoblastomycosis, and mucormycosis.

Indexed as

IodideiodineKIpotassium iodideSSKI

Identifiers

PMID40487487
PMCPMC12139630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.